Corporate Governance1 Sept 2026, 03:34 pm
Symbiotec Pharmalab Authorizes KMPs for Materiality Decisions
AI Summary
Symbiotec Pharmalab Ltd has disclosed the individuals authorized to determine the materiality of events or information and make necessary disclosures to stock exchanges, as per SEBI Listing Regulations. The Chairman & Managing Director, Anil Satwani, along with the Chief Financial Officer, Raghavender Ramachandran, and the Company Secretary & Compliance Officer, Salil Jain, are empowered to make these crucial determinations. This move ensures compliance with regulatory requirements for timely and accurate information dissemination.
Key Highlights
- Key Managerial Personnel authorized to determine event materiality.
- Compliance with SEBI Listing Obligations and Disclosure Requirements.
- Chairman & MD, CFO, and CS are designated authorities.
- Ensures timely and accurate disclosures to stock exchanges.
Price Impact
More from SYMBIOTEC